Snake venom hyaluronidase: a therapeutic target
Related Experiment Video
Updated: Aug 15, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
Published on: October 6, 2023
1Department of Biochemistry, University of Mysore, Mysore--570 006, India. kemparaj@rediffmail.com
Abstract:
The diffusion of toxins from the site of a bite into the circulation is essential for successful envenomation. Degradation of hyaluronic acid in the extracellular matrix (ECM) by venom hyaluronidase is a key factor in this diffusion. Hyaluronidase not only increases the potency of other toxins but also damages the local tissue. In spite of its important role, little attention has been paid to this enzyme. Hyaluronidase exists in various isoforms and generates a wide range of hyaluronic acid degradation products. This suggests that beyond its role as a spreading factor venom hyaluronidase deserves to be explored as a possible therapeutic target for inhibiting the systemic distribution of venom and also for minimizing local tissue destruction at the site of the bite.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Determinants of Bacterial Pathogenicity and Virulence
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

